P. falciparum CG2, Linked to Chloroquine Resistance, Does Not Resemble Na+/H+ Exchangers  by Wellems, Thomas E. et al.
Cell, Vol. 94, 285±286, August 7, 1998, Copyright 1998 by Cell Press
Matters Arising
occurs in known exchanger proteins, is highly im-P. falciparum CG2, Linked
probable.to Chloroquine Resistance, Does Not
Second, the sodium/hydrogen ion transport domainResemble Na1/H1 Exchangers homology proposed by Sanchez et al. (1998), and the
results of database searches, have been reanalyzed by
Understanding the molecular basis for chloroquine re- established statistical methods (Altschul et al., 1994;
Altschul and Gish, 1996). No pairwise alignment scoressistance in Plasmodium falciparum will provide impor-
tant support for the development of new therapies and between the proposed CG2 domain and known NHE
transport domains approach even borderline statisticalprophylactic measures against malaria. Complementary
genetic and biochemical investigations should discrimi- significance. All of these scores have a 0.8 probability
or greater of occurring in random pairwise alignmentsnate among current theories and pinpoint the functional
determinants of resistance. With this in mind, Sanchez of protein sequences with the same sizes and composi-
tions. Moreover, the proposed CG2 domain shows con-et al. (1998) have proposed that the P. falciparum cg2
gene, linked by Suet al. (1997) to chloroquine resistance, siderably stronger (but still nonsignificant) scores in
alignments with many proteins in current databases thatmay encode a sodium/hydrogen exchanger (NHE) re-
sponsible for drug transport. Here, we present evidence are not transporters.
Third, Sanchez et al. (1998) claim that the motifagainst this proposal. Detailed reanalysis of the CG2
sequence fails to support the claims for significant simi- VFFLFSI in CG2 resembles the characteristic amiloride
binding signatureVFFLFLL inNHE sequences. They givelarity to functional features of well-characterized eukary-
otic NHE transport domains. a probability of 8 3 1024 for the chance occurrence of
VFFLF in a random sequence of CG2's size and compo-First, although the CG2 sequence has some clusters
of hydrophobic amino acids, these are not typical of sition. However, the actual chance of finding a similar
or stronger match to VFFLFLL in P. falciparum proteinsknown types of integral membrane proteins, including
those from P. falciparum. Of the seven potential trans- is much greater than this because of the strong, nonran-
dom, compositional bias and amino acid clusteringmembrane segments annotated on the CG2 sequence
in Figure 3 of Su et al. (1997), six gave only marginal characteristic of this parasite. The residues encoded by
AU-rich codon sets (such as F, L, I, N, K, and Y) in P.predictions in the three algorithms used. Figure 1 shows
results from two additional well-validated algorithms, falciparum are unusually abundant, and these amino
acids also have a strong tendency to occur clusteredTMHMM (Sonnhammer et al., 1998) and MEMSAT (Jones
et al., 1994), which evaluate potential transmembrane together in low complexity regions. An analysis of 729
nonidentical P. falciparum amino acid translations avail-helices together with characteristic flanking loop se-
quences. When applied to known mammalian NHE able from public databases showed 126 clusters ($10
contiguous amino acids) containing at least 70% F/L.sequences, both methods successfully predict 10±12
transmembrane regions and much of their known con- To avoid bias in this analysis, candidate N-terminal hy-
drophobic signal sequences were excluded from thenectivity topology, yet these methods give negative
results for the CG2 sequence (Figure 1). Hydrophobicity count. Therefore, the VFFLF match in CG2 is not surpris-
ing, and there is no statistical reason for attributing spe-profiles of NHE proteins show large peaks,whereas CG2
shows, at most, only marginal spikes of local hydropho- cial functional significance to this motif.
Additionally, our immunoelectronmicroscopy studiesbicity (Figure 1). It is an open question which, if any, of
these short, widely separated hydrophobic clusters in do not show the plasma membrane localization that
would be expected if CG2 were an integral membraneCG2 have the potential to span a membrane. The pres-
ence of more than seven transmembrane segments, as NHE. Figure 5 of Su et al. (1997) showed that CG2 in
Figure 1. Hydrophobicity and Transmembrane Analyses Demonstrate Substantial Differences between the CG2 Protein and Typical NHE
Exchangers
Average hydrophobicity was plotted over a 17-residue window (Kyte-Doolittle parameters) for the human amiloride-sensitive sodium/hydrogen
exchanger NAH1 (GenBank protein sequence ID 178753, Swiss-Prot P19634; other NHE sequences not shown give similar results) and the
CG2 protein sequence of the chloroquine-resistant Dd2 clone. The horizontal line intersecting each curve represents an accepted diagnostic
threshold typically exceeded by candidates for transmembrane helices. The solid blocks above the curves represent the transmembrane
helices predicted by TMHMM and MEMSAT. Scale bars indicate amino acid sequence numbers.
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sets show simple saturation effects (for example, linear
Scatchard or Hill plots) in the nanomolar range of extra-
cellular chloroquine, but such data alone cannot distin-
guish between the formal kinetic schemata of active
transport or intracellular sequestration. An altered asso-
ciation constant of chloroquine±hematin binding or re-
duction of chloroquine availability to hematin via a non±
membrane-dependent mechanism, as supported by the
experiments of Bray et al. (1998), would be consistent
with a resistance factor that acts in direct association
with hematin inside vesicles where CG2 is found (Su et
al., 1997).
CG2 may thus affect chloroquine access, processes
related to hemoglobin digestion, heme sequestration,
or the toxicity of hematin±chloroquine complexes. In-
vestigations including gene modifications and biochem-
ical assays will be required tounderstand the fascinating
interactions of this unique protein and its role in chlo-
roquine resistance.
Figure 2. Immunoelectron Micrograph Showing Location of CG2
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